agilon health, inc. (NYSE:AGL) Receives Average Recommendation of “Hold” from Brokerages

Shares of agilon health, inc. (NYSE:AGL) have been assigned a consensus rating of “Hold” from the eighteen research firms that are covering the company, Marketbeat reports. Two research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among analysts that have issued a report on the stock in the last year is $4.03.

Several equities analysts have recently issued reports on the company. Citigroup upgraded agilon health from a “sell” rating to a “neutral” rating and boosted their target price for the stock from $1.75 to $2.25 in a research report on Friday, January 10th. Macquarie began coverage on agilon health in a research report on Monday, December 16th. They set a “neutral” rating and a $3.00 target price for the company. JMP Securities lowered agilon health from an “outperform” rating to a “market perform” rating in a research report on Monday, November 11th. Royal Bank of Canada reiterated an “outperform” rating and issued a $3.00 price objective on shares of agilon health in a research report on Tuesday, November 19th. Finally, Needham & Company LLC started coverage on agilon health in a research note on Friday, January 10th. They issued a “hold” rating on the stock.

agilon health Stock Up 4.1 %

Shares of AGL stock opened at $3.57 on Thursday. The stock has a fifty day moving average price of $2.64 and a 200 day moving average price of $3.24. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health has a one year low of $1.50 and a one year high of $7.73. The stock has a market cap of $1.47 billion, a P/E ratio of -3.80 and a beta of 0.67.

Insider Buying and Selling at agilon health

In related news, Director John William Wulf bought 45,000 shares of the business’s stock in a transaction that occurred on Thursday, December 5th. The shares were bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now directly owns 206,133 shares in the company, valued at approximately $449,369.94. This represents a 27.93 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Diana Mckenzie bought 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The shares were bought at an average cost of $2.28 per share, for a total transaction of $28,500.00. Following the transaction, the director now owns 51,319 shares of the company’s stock, valued at $117,007.32. The trade was a 32.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders bought 90,000 shares of company stock worth $198,100. 3.20% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of AGL. JPMorgan Chase & Co. raised its stake in shares of agilon health by 326.4% in the third quarter. JPMorgan Chase & Co. now owns 1,415,419 shares of the company’s stock valued at $5,563,000 after buying an additional 1,083,492 shares during the period. Inspire Investing LLC increased its position in shares of agilon health by 106.6% during the 4th quarter. Inspire Investing LLC now owns 217,550 shares of the company’s stock valued at $413,000 after purchasing an additional 112,241 shares during the last quarter. Citigroup Inc. boosted its holdings in agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after acquiring an additional 1,941,993 shares during the period. Geode Capital Management LLC lifted its holdings in agilon health by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company’s stock worth $27,097,000 after buying an additional 84,889 shares during the period. Finally, State Street Corp lifted its stake in shares of agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after purchasing an additional 215,733 shares during the period.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.